In Vitro Diagnostics (IVD) Quality Controls Market by Application (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology) Source (Serum, Blood, Plasma Based Controls) Type (Instrument Specific & Third Party Controls) - Forecast to 2020

体外診断(IVD)品質管理の世界市場:全血ベース管理、血清ベース管理、血漿ベース管理、尿ベース管理

◆タイトル:In Vitro Diagnostics (IVD) Quality Controls Market by Application (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology) Source (Serum, Blood, Plasma Based Controls) Type (Instrument Specific & Third Party Controls) - Forecast to 2020
◆商品コード:MAM-MD-4180
◆調査・発行会社:MarketsandMarkets
◆発行日:2016年3月21日
◆ページ数:221
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、体外診断(IVD)品質管理の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、用途別分析、ソース別分析、種類別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global in vitro diagnostics quality control products market is estimated to reach USD 979.0 Million by 2020, growing at a CAGR of 3.6% during the forecast period of 2015 to 2020. This market is mainly driven by the growing number of accredited clinical laboratories across the globe and rising need to ensure the accuracy and reliability of diagnostic test results.

In this report, the IVD Quality Controls market is segmented based on product type, applications, manufacturer type, end users, and region. This research report discusses key market drivers, restraints, opportunities, and challenges in the global In Vitro Diagnostics Quality Controls market and its submarkets.

Based on product type, the market is segmented into quality controls, data management solutions, and quality assurance services. The quality controls segment accounted for the largest share of the In Vitro Diagnostics Quality Controls products market, by type, in 2015; it is also expected to grow at the highest CAGR during the forecast period of 2015 to 2020. The large share of this segment is mainly attributed to the increasing availability & demand for technologically advanced quality control materials with greater stability. The growing number of accredited clinical laboratories and mandates on these laboratories to perform quality control tests is driving the growth of the In Vitro Diagnostics Quality Controls market.

Based on applications, the IVD quality controls market is segmented into the clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation/hemostasis, microbiology, and other applications. The immunochemistry segment accounted for the largest share of the In Vitro Diagnostics Quality Controls market in 2015. The large share of this segment can be attributed to the increasing number of multi-analyte controls to perform immunoassay tests. However, the molecular diagnostics segment is the fastest-growing segment in the In Vitro Diagnostics Quality Controls applications market, mainly due to the increasing number of molecular diagnostic tests performed in laboratories and the rising need to ensure the accuracy of these complex diagnostic tests.

In 2015, North America represented the largest regional market for IVD quality controls, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Although North America will continue to dominate the global In Vitro Diagnostics Quality Controls market during the forecast period, the Asia-Pacific region is expected to be the fastest-growing geographic market in the coming years. A majority of the growth in this region is driven by the rapid increase in the number of accredited laboratories and increasing use of quality control products by clinical laboratories in this region.

The major players in the global In Vitro Diagnostics Quality Controls market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Randox Laboratories (U.K.), Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Siemens Healthcare (Germany), and Sysmex Corporation (Japan).

【レポートの目次】

1 Introduction (Page No. – 19)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 30)

4 Premium Insights (Page No. – 35)
4.1 Growth Potential of the Market
4.2 Asia-Pacific: Market
4.3 IVD Quality Control Products Market: Geographic Snapshot
4.4 Geographic Mix: IVD Quality Control Products Market
4.5 IVD Quality Control Products Market: Emerging vs. Developed Markets

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Segmentation
5.2.1 IVD Quality Control Products Market, By Type
5.2.2 Market, By Application
5.2.3 Market, By Manufacturer Type
5.2.4 Market, By End User
5.3 Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Growing Number of Accredited Clinical Laboratories
5.3.1.2 Increasing Adoption of Third-Party Quality Controls
5.3.2 Market Restraints
5.3.2.1 Additional Cost Involved in Quality Control, Budget Constraints in Hospitals and Laboratories
5.3.2.2 Unfavorable Reimbursement Scenario in the IVD Industry
5.3.3 Market Opportunity
5.3.3.1 Rising Demand for Multi-Analyte Controls
5.3.4 Market Challenges
5.3.4.1 Stringent Product Approval Process
5.3.4.2 Lack of Proper Regulations and Non-Compliance to Regulations

6 Industry Insights (Page No. – 49)
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Adoption of Third-Party Quality Controls
6.2.2 Increasing Focus of Customers Towards the Use of External Quality Assurance Support From Manufacturers
6.3 Porter’s Five Force Analysis
6.3.1 Threat of New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry
6.4 Regulatory Analysis
6.4.1 North America
6.4.1.1 U.S.
6.4.1.2 Canada
6.4.2 Europe
6.4.3 Asia-Pacific
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 India

7 Global IVD Quality Controls Products Market, By Type (Page No. – 57)
7.1 Introduction
7.2 Quality Controls
7.2.1 Whole-Blood-Based Controls
7.2.2 Serum-Based Controls
7.2.3 Plasma-Based Controls
7.2.4 Urine-Based Controls
7.2.5 Other IVD Quality Controls
7.3 Data Management Solutions
7.4 Quality Assurance Services

8 Global IVD Quality Controls Market, By Application (Page No. – 69)
8.1 Introduction
8.2 Clinical Chemistry
8.3 Immunochemistry
8.4 Hematology
8.5 Molecular Diagnostics
8.6 Coagulation/Hemostasis
8.7 Microbiology
8.8 Others

9 Global IVD Quality Controls Market, By End User (Page No. – 80)
9.1 Introduction
9.2 Hospitals
9.3 Clinical Laboratories
9.4 Research and Academic Institutes
9.5 Others

10 IVD Quality Controls Market, By Manufacturer Type (Page No. – 87)
10.1 Introduction
10.2 Instrument Manufacturer Controls
10.3 Independent Manufacturer Controls
10.3.1 Third-Party Controls
10.3.2 Instrument-Specific Controls

11 Geographic Analysis (Page No. – 94)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe (RoE)
11.4 Asia-Pacific (APAC)
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific (RoAPAC)
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America (RoLA)
11.6 Middle East and Africa

12 Company Profiles (Page No. – 156)
12.1 Abbott Diagnostics
12.2 Bio-Rad Laboratories, Inc.
12.3 Roche Diagnostics
12.4 Thermo Fisher Scientific, Inc.
12.5 Randox Laboratories Ltd.
12.6 Helena Laboratories
12.7 Sero as
12.8 Seracare Life Sciences, Inc.
12.9 Technopath Clinical Diagnostics
12.10 Sun Diagnostics, LLC.
12.11 Siemens Healthcare
12.12 Sysmex Corporation
12.13 Danaher Corporation
12.14 Ortho Clinical Diagnostics, Inc.

*Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Competitive Landscape (Page No. – 192)
13.1 Overview
13.2 Market Share Analysis
13.3 Competitive Situation and Trends
13.4 New Product Launches
13.5 Agreements, Partnerships, and Collaborations
13.6 Mergers and Acquisitions
13.7 Expansions

14 Appendix (Page No. – 200)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Other Developments, January 2012–January 2016
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports

List of Tables (144 Tables)

Table 1 Market Drivers: Impact Analysis
Table 2 Market Restraints: Impact Analysis
Table 3 Market Opportunities: Impact Analysis
Table 4 In Vitro Diagnostics Quality Controls Market Challenges: Impact Analysis
Table 5 Accreditation Bodies for Quality Systems for Medical Laboratories in Europe
Table 6 Products Market Size, By Type,2013–2020 (USD Million)
Table 7 Global In Vitro Diagnostics Quality Controls Market Size, By Source Type,2013–2020 (USD Million)
Table 8 Global In Vitro Diagnostics Quality Controls Market Size, By Country,2013–2020 (USD Million)
Table 9 Global Whole-Blood-Based Quality Controls Market Size, By Country, 2013–2020 (USD Million)
Table 10 Global Serum-Based Quality Controls Market Size, By Country, 2013–2020 (USD Million)
Table 11 Global Plasma-Based Quality Controls Market Size, By Country, 2013–2020 (USD Million)
Table 12 Global Urine-Based Quality Controls Market Size, By Country, 2013–2020 (USD Million)
Table 13 Global Other Market Size, By Country, 2013–2020 (USD Million)
Table 14 Global In Vitro Diagnostics Quality Controls Data Management Solutions Market Size, By Country, 2013–2020 (USD Million)
Table 15 Global IVD Quality Assurance Services Market Size, By Country, 2013–2020 (USD Million)
Table 16 Global IVD Quality Controls Market Size, By Application, 2013–2020 (USD Million)
Table 17 Global IVD Quality Controls Market Size for Clinical Chemistry, By Country, 2013–2020 (USD Million)
Table 18 Global Market Size for Immunochemistry, By Country, 2013–2020 (USD Million)
Table 19 Global Market Size for Hematology, By Country, 2013–2020 (USD Million)
Table 20 Global Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 21 Global Market Size for Coagulation and Hemostasis, By Country, 2013–2020 (USD Million)
Table 22 Global Market Size for Microbiology, By Country, 2013–2020 (USD Million)
Table 23 Global Quality Controls Market Size for Other Applications, By Country, 2013–2020 (USD Million)
Table 24 Global Market Size, By End User, 2013–2020 (USD Million)
Table 25 Global Market Size for Hospitals, By Country, 2013–2020 (USD Million)
Table 26 Global Market Size for Clinical Laboratories, By Country, 2013–2020 (USD Million)
Table 27 Global Market Size for Research and Academic Institutes, By Country, 2013–2020 (USD Million)
Table 28 Global Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 29 Global Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 30 Global Instrument Manufacturer Controls Market Size, By Country, 2013–2020 (USD Million)
Table 31 Global Independent Manufacturer Controls Market Size, By Type, 2013–2020 (USD Million)
Table 32 Global Independent Manufacturer Controls Market Size, By Country, 2013–2020 (USD Million)
Table 33 Global Third-Party Quality Controls Market Size, By Country, 2013–2020 (USD Million)
Table 34 Global Instrument-Specific Controls Market Size, By Country, 2013–2020 (USD Million)
Table 35 Global Products Market Size, By Region, 2013–2020 (USD Million)
Table 36 Global Products Market Size, By Country, 2013–2020 (USD Million)
Table 37 North America: Products Market Size, By Country, 2013–2020 (USD Million)
Table 38 North America: Products Market Size, By Type, 2013–2020 (USD Million)
Table 39 North America: In Vitro Diagnostics Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
Table 40 North America: In Vitro Diagnostics Quality Controls Market Size, By Application, 2013–2020 (USD Million)
Table 41 North America: In Vitro Diagnostics Quality Controls Market Size, By End User, 2013–2020 (USD Million)
Table 42 North America: IVD Quality Controls Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 43 U.S.: Products Market Size, By Type, 2013–2020 (USD Million)
Table 44 U.S.: Market Size, By Source Type, 2013–2020 (USD Million)
Table 45 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 46 U.S.: Market Size, By End User,2013–2020 (USD Million)
Table 47 U.S.: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 48 Canada: IVD Quality Control Products Market Size, By Type, 2013–2020 (USD Million)
Table 49 Canada: Market Size, By Source Type, 2013–2020 (USD Million)
Table 50 Canada: Market Size, By Application, 2013–2020 (USD Million)
Table 51 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 52 Canada: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 53 Europe: Products Market Size, By Country, 2013–2020 (USD Million)
Table 54 Europe: Products Market Size, By Type, 2013–2020 (USD Million)
Table 55 Europe: Market Size, By Source Type, 2013–2020 (USD Million)
Table 56 Europe: Market Size, By Application, 2013–2020 (USD Million)
Table 57 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 58 Europe: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 59 Germany: Products Market Size, By Type, 2013–2020 (USD Million)
Table 60 Germany: IVD Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
Table 61 Germany: Market Size, By Application, 2013–2020 (USD Million)
Table 62 Germany: Market Size, By End User, 2013–2020 (USD Million)
Table 63 Germany: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 64 France: Products Market Size, By Type, 2013–2020 (USD Million)
Table 65 France: IVD Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
Table 66 France: Market Size, By Application, 2013–2020 (USD Million)
Table 67 France: Market Size, By End User, 2013–2020 (USD Million)
Table 68 France: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 69 U.K.: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
Table 70 U.K.: Market Size, By Source Type, 2013–2020 (USD Million)
Table 71 U.K.: Market Size, By Application, 2013–2020 (USD Million)
Table 72 U.K.: Market Size, By End User, 2013–2020 (USD Million)
Table 73 U.K.: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 74 Italy: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
Table 75 Italy: Market Size, By Source Type, 2013–2020 (USD Million)
Table 76 Italy: Market Size, By Application, 2013–2020 (USD Million)
Table 77 Italy: Market Size, By End User,2013–2020 (USD Million)
Table 78 Italy: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 79 Spain: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
Table 80 Spain: Market Size, By Source Type, 2013–2020 (USD Million)
Table 81 Spain: Market Size, By Application, 2013–2020 (USD Million)
Table 82 Spain: Market Size, By End User,2013–2020 (USD Million)
Table 83 Spain: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 84 RoE: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
Table 85 RoE: Market Size, By Source Type, 2013–2020 (USD Million)
Table 86 RoE: Market Size, By Application, 2013–2020 (USD Million)
Table 87 RoE: Market Size, By End User,2013–2020 (USD Million)
Table 88 RoE: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 89 APAC: IVD Quality Controls Products Market Size, By Country, 2013–2020 (USD Million)
Table 90 APAC: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
Table 91 APAC: Market Size, By Source Type, 2013–2020 (USD Million)
Table 92 APAC: Market Size, By Application, 2013–2020 (USD Million)
Table 93 APAC: Market Size, By End User,2013–2020 (USD Million)
Table 94 APAC: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 95 Japan: Products Market Size, By Type,2013–2020 (USD Million)
Table 96 Japan: IVD Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
Table 97 Japan: Market Size, By Application, 2013–2020 (USD Million)
Table 98 Japan: Market Size, By End User,2013–2020 (USD Million)
Table 99 Japan: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 100 China: Products Market Size, By Type, 2013–2020 (USD Million)
Table 101 China: IVD Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
Table 102 China: In Vitro Diagnostics Quality Controls Market Size, By Application, 2013–2020 (USD Million)
Table 103 China: Market Size, By End User,2013–2020 (USD Million)
Table 104 China: In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 105 India: Products Market Size, By Type, 2013–2020 (USD Million)
Table 106 India: In Vitro Diagnostics Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
Table 107 India: In Vitro Diagnostics Quality Controls Market Size, By Application, 2013–2020 (USD Million)
Table 108 India: In Vitro Diagnostics Quality Controls Market Size, By End User,2013–2020 (USD Million)
Table 109 India: In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 110 RoAPAC: Products Market Size, By Type, 2013–2020 (USD Million)
Table 111 RoAPAC: IVD Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
Table 112 RoAPAC: Market Size, By Application, 2013–2020 (USD Million)
Table 113 RoAPAC: Market Size, By End User, 2013–2020 (USD Million)
Table 114 RoAPAC: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 115 Latin America: Products Market Size, By Country, 2013–2020 (USD Million)
Table 116 Latin America: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
Table 117 Latin America: Market Size, By Source Type, 2013–2020 (USD Million)
Table 118 Latin America: Market Size, By Application, 2013–2020 (USD Million)
Table 119 Latin America: Market Size, By End User, 2013–2020 (USD Million)
Table 120 Latin America: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 121 Brazil: IVD Quality Control Products Market Size, By Type, 2013–2020 (USD Million)
Table 122 Brazil: Market Size, By Source Type, 2013–2020 (USD Million)
Table 123 Brazil: Market Size, By Application, 2013–2020 (USD Million)
Table 124 Brazil: Products Market Size, By End User, 2013–2020 (USD Million)
Table 125 Brazil: Products Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 126 Mexico: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
Table 127 Mexico: In Vitro Diagnostics Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
Table 128 Mexico: IVD Quality Controls Market Size, By Application, 2013–2020 (USD Million)
Table 129 Mexico: IVD Quality Controls Market Size, By End User, 2013–2020 (USD Million)
Table 130 Mexico: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 131 RoLA: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
Table 132 RoLA: Market Size, By Source Type, 2013–2020 (USD Million)
Table 133 RoLA: Market Size, By Application, 2013–2020 (USD Million)
Table 134 RoLA: Market Size, By End User,2013–2020 (USD Million)
Table 135 RoLA: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 136 Middle East and Africa: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
Table 137 Middle East and Africa: Market Size, By Source Type, 2013–2020 (USD Million)
Table 138 Middle East and Africa: Market Size, By Application, 2013–2020 (USD Million)
Table 139 Middle East and Africa: Market Size, By End User, 2013–2020 (USD Million)
Table 140 Middle East and Africa: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
Table 141 New Product Launches, January 2012–January 2016
Table 142 Agreements, Partnerships, and Collaborations, January 2012–January 2016
Table 143 Mergers and Acquisitions, January 2012–January 2016
Table 144 Expansions, January 2012–January 2016

List of Figures (41 Figures)

Figure 1 Global IVD Quality Controls Products Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global IVD Quality Controls Products Market Size, By Type, 2015 vs. 2020 (USD Million)
Figure 7 Global In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type,2015 vs. 2020 (USD Million)
Figure 8 Global In Vitro Diagnostics Quality Controls Market Size, By End User, 2015 vs. 2020 (USD Million)
Figure 9 Global In Vitro Diagnostics Quality Controls Market Size, By Application, 2015 vs. 2020 (USD Million)
Figure 10 In Vitro Diagnostics Quality Controls Market: Geographic Snapshot
Figure 11 Increasing Number of Accredited Laboratories is Driving the Growth of the In Vitro Diagnostics Quality Controls Market
Figure 12 Serum-Based Controls to Account for the Largest Share of the In Vitro Diagnostics Quality Controls Market in Asia-Pacific
Figure 13 U.S. to Command Almost Half of the Global In Vitro Diagnostics Quality Controls Market
Figure 14 North America to Dominate the In Vitro Diagnostics Quality Controls Market During the Forecast Period
Figure 15 Emerging Markets Estimated to Grow at the Highest Rate During the Forecast Period
Figure 16 Products Market, By Type
Figure 17 Market, By Application
Figure 18 Market, By Manufacturer Type
Figure 19 In Vitro Diagnostics Quality ControlsMarket, By End User
Figure 20 In Vitro Diagnostics Quality Controls Market: Drivers, Restraints, Opportunities, & Challenges
Figure 21 Number of Accredited Medical Laboratories in Europe, 2011-2014
Figure 22 Number of Accredited Medical Laboratories in Japan, Australia, India, and Canada: June-2011-March 2015
Figure 23 Quality Controls Segment to Witness the Highest Growth During the Forecast Period
Figure 24 Molecular Diagnostics Will Grow at the Highest CAGR During the Forecast Period of 2015-2020
Figure 25 Clinical Laboratories is the Fastest Growing End-User Segment of the Market During the Forecast Period
Figure 26 Independent Manufacturer Controls Segment to Witness Highest Growth During the Forecast Period
Figure 27 North America to Dominate the v Products Market
Figure 28 North America Market Snapshot
Figure 29 Europe Market Snapshot
Figure 30 Accredited Clinical Laboratories in Mexico: 2005-2015
Figure 31 Geographic Revenue Mix of the Top 5 Market Players
Figure 32 Company Snapshot: Abbott Laboratories, Inc.
Figure 33 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 34 Company Snapshot: F. Hoffmann-La Roche Ltd.
Figure 35 Company Snapshot: Thermo Fisher Scientific, Inc.
Figure 36 Company Snapshot: Siemens AG
Figure 37 Company Snapshot: Sysmex Corporation
Figure 38 Company Snapshot: Danaher Corporation
Figure 39 Players Majorly Adopted the Strategy of New Product Launches From January 2012 to January 2016
Figure 40 Global in Vitro Diagnostics Quality Control Products Market Share Analysis, By Key Player, 2014
Figure 41 Battle for Market Share: New Product Launches Was the Key Strategy

【レポートのキーワード】

体外診断(IVD)、IVD品質管理、全血ベース管理、血清ベース管理、血漿ベース管理、尿ベース管理、免疫測定、臨床化学、分子診断、微生物学、装置、医療機器

★調査レポート[体外診断(IVD)品質管理の世界市場:全血ベース管理、血清ベース管理、血漿ベース管理、尿ベース管理] ( In Vitro Diagnostics (IVD) Quality Controls Market by Application (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology) Source (Serum, Blood, Plasma Based Controls) Type (Instrument Specific & Third Party Controls) - Forecast to 2020 / MAM-MD-4180) 販売に関する免責事項
[体外診断(IVD)品質管理の世界市場:全血ベース管理、血清ベース管理、血漿ベース管理、尿ベース管理] ( In Vitro Diagnostics (IVD) Quality Controls Market by Application (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology) Source (Serum, Blood, Plasma Based Controls) Type (Instrument Specific & Third Party Controls) - Forecast to 2020 / MAM-MD-4180) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆